BCL2 and breast carcinoma: The capacity of SHBG to suppress bcl-2 expression counteracts the typical gene amplification caused by estradiol, which may be one of the mechanisms of SHBG binding to its membrane receptor and then combining with estrogen to induce recovery of apoptosis in breast cancer cells.